| Revenue growth | 2% YoY in Q4; 3% YoY for FY26. |
|---|---|
| Margins | Operating EBITDA margin compressed to 25% for FY26 from 29% in FY25. |
| Demand visibility | Strong; ~400 active clients, 16 of top 20 pharma companies. |
| Management confidence | High; expanding leadership team and multi-modal facilities. |
Growth
Q4 FY26 Revenue grew 2% YoY; PAT before exceptional items fell 16% YoY. Full year FY26 Revenue grew 3% YoY.
Outlook
Investments in peptides, ADCs, and Biologics; infrastructure expansion in Bangalore, Hyderabad, and Baltimore site acquisition.
Risks
PAT decline due to lower margins (29% vs 34% in Q4 FY25) and foreign exchange volatility.
Earnings Call filed with BSE, NSE: SYNGENE. Summary written with AI assistance from the document.
Syngene International Ltd: key numbers
- Share price
- ₹360.15
- Market cap
- ₹14,538 Cr
- Revenue (annual)
- ₹3,739 Cr
- Net profit (annual)
- ₹316.7 Cr
- P/E (TTM)
- 65.8×Sector 47.4×
- Promoter holding
- 52.59%-0.09% QoQ
- FII holding
- 11.82%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Syngene International Ltd
All →Syngene International Management Change
Syngene International Limited announced the resignation of Mr. Pramuch Goel, Head of Corporate Affairs & Communications and Senior Management Personnel, effective September 21, 2026.
Syngene International Other Announcement
Syngene International Limited has issued a communication to shareholders regarding the remittance of the final dividend for the financial year 2025-26.
Syngene International Employee Stock Options
Syngene International has granted 14,26,061 Performance Share Units (PSUs) to eligible employees under the company's 2023 Long Term Incentive Performance Share Plan.
Syngene International Acquisition Worth ₹2.52 Cr
Syngene International Limited is investing ₹2.52 Crore to acquire a 12.44% equity stake in Ampin C&I Power Twelve Private Limited for renewable energy power consumption.
- Value
- ₹2.52 Cr
Syngene International Investor Presentation: Key Takeaways
Syngene reports Q1 FY27 revenue of Rs 736 Cr (-16% YoY). Performance was impacted by low offtake from a major client and forex losses.
Syngene International Annual General Meeting
Syngene International Limited held its 33rd Annual General Meeting on July 29, 2026. The meeting transacted business including the adoption of financial statements and dividend declaration.